US3856818A - Tricyclic phenoxy aminopropanols - Google Patents

Tricyclic phenoxy aminopropanols Download PDF

Info

Publication number
US3856818A
US3856818A US00268313A US26831372A US3856818A US 3856818 A US3856818 A US 3856818A US 00268313 A US00268313 A US 00268313A US 26831372 A US26831372 A US 26831372A US 3856818 A US3856818 A US 3856818A
Authority
US
United States
Prior art keywords
lower alkyl
tetrahydro
cis
amino
mixture
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
US00268313A
Inventor
F Hauck
C Cimarusti
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
ER Squibb and Sons LLC
Original Assignee
ER Squibb and Sons LLC
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by ER Squibb and Sons LLC filed Critical ER Squibb and Sons LLC
Priority to US00268313A priority Critical patent/US3856818A/en
Priority to CA173,628A priority patent/CA1000287A/en
Priority to GB2818773A priority patent/GB1434225A/en
Priority to DE2332706A priority patent/DE2332706A1/en
Priority to HUSU823A priority patent/HU167178B/hu
Priority to CH963073A priority patent/CH577459A5/xx
Priority to BE133067A priority patent/BE801848A/en
Priority to NL7309236A priority patent/NL7309236A/xx
Priority to JP48076473A priority patent/JPS4955652A/ja
Priority to FR7324448A priority patent/FR2190463B1/fr
Priority to AR248898A priority patent/AR201666A1/en
Application granted granted Critical
Publication of US3856818A publication Critical patent/US3856818A/en
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D307/00Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom
    • C07D307/77Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom ortho- or peri-condensed with carbocyclic rings or ring systems
    • C07D307/92Naphthofurans; Hydrogenated naphthofurans
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D263/00Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings
    • C07D263/52Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings condensed with carbocyclic rings or ring systems
    • C07D263/60Naphthoxazoles; Hydrogenated naphthoxazoles
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D303/00Compounds containing three-membered rings having one oxygen atom as the only ring hetero atom
    • C07D303/02Compounds containing oxirane rings
    • C07D303/12Compounds containing oxirane rings with hydrocarbon radicals, substituted by singly or doubly bound oxygen atoms
    • C07D303/18Compounds containing oxirane rings with hydrocarbon radicals, substituted by singly or doubly bound oxygen atoms by etherified hydroxyl radicals
    • C07D303/20Ethers with hydroxy compounds containing no oxirane rings
    • C07D303/24Ethers with hydroxy compounds containing no oxirane rings with polyhydroxy compounds
    • C07D303/26Ethers with hydroxy compounds containing no oxirane rings with polyhydroxy compounds having one or more free hydroxyl radicals
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D317/00Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms
    • C07D317/08Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms having the hetero atoms in positions 1 and 3
    • C07D317/44Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms having the hetero atoms in positions 1 and 3 ortho- or peri-condensed with carbocyclic rings or ring systems
    • C07D317/70Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms having the hetero atoms in positions 1 and 3 ortho- or peri-condensed with carbocyclic rings or ring systems condensed with ring systems containing two or more relevant rings
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D319/00Heterocyclic compounds containing six-membered rings having two oxygen atoms as the only ring hetero atoms
    • C07D319/101,4-Dioxanes; Hydrogenated 1,4-dioxanes
    • C07D319/141,4-Dioxanes; Hydrogenated 1,4-dioxanes condensed with carbocyclic rings or ring systems
    • C07D319/221,4-Dioxanes; Hydrogenated 1,4-dioxanes condensed with carbocyclic rings or ring systems condensed with one naphthalene or hydrogenated naphthalene ring system
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D333/00Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom
    • C07D333/50Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom condensed with carbocyclic rings or ring systems
    • C07D333/74Naphthothiophenes
    • CCHEMISTRY; METALLURGY
    • C10PETROLEUM, GAS OR COKE INDUSTRIES; TECHNICAL GASES CONTAINING CARBON MONOXIDE; FUELS; LUBRICANTS; PEAT
    • C10MLUBRICATING COMPOSITIONS; USE OF CHEMICAL SUBSTANCES EITHER ALONE OR AS LUBRICATING INGREDIENTS IN A LUBRICATING COMPOSITION
    • C10M2215/00Organic non-macromolecular compounds containing nitrogen as ingredients in lubricant Compositions
    • C10M2215/02Amines, e.g. polyalkylene polyamines; Quaternary amines
    • C10M2215/04Amines, e.g. polyalkylene polyamines; Quaternary amines having amino groups bound to acyclic or cycloaliphatic carbon atoms
    • C10M2215/042Amines, e.g. polyalkylene polyamines; Quaternary amines having amino groups bound to acyclic or cycloaliphatic carbon atoms containing hydroxy groups; Alkoxylated derivatives thereof
    • CCHEMISTRY; METALLURGY
    • C10PETROLEUM, GAS OR COKE INDUSTRIES; TECHNICAL GASES CONTAINING CARBON MONOXIDE; FUELS; LUBRICANTS; PEAT
    • C10MLUBRICATING COMPOSITIONS; USE OF CHEMICAL SUBSTANCES EITHER ALONE OR AS LUBRICATING INGREDIENTS IN A LUBRICATING COMPOSITION
    • C10M2215/00Organic non-macromolecular compounds containing nitrogen as ingredients in lubricant Compositions
    • C10M2215/086Imides [having hydrocarbon substituents containing less than thirty carbon atoms]
    • CCHEMISTRY; METALLURGY
    • C10PETROLEUM, GAS OR COKE INDUSTRIES; TECHNICAL GASES CONTAINING CARBON MONOXIDE; FUELS; LUBRICANTS; PEAT
    • C10MLUBRICATING COMPOSITIONS; USE OF CHEMICAL SUBSTANCES EITHER ALONE OR AS LUBRICATING INGREDIENTS IN A LUBRICATING COMPOSITION
    • C10M2215/00Organic non-macromolecular compounds containing nitrogen as ingredients in lubricant Compositions
    • C10M2215/22Heterocyclic nitrogen compounds
    • CCHEMISTRY; METALLURGY
    • C10PETROLEUM, GAS OR COKE INDUSTRIES; TECHNICAL GASES CONTAINING CARBON MONOXIDE; FUELS; LUBRICANTS; PEAT
    • C10MLUBRICATING COMPOSITIONS; USE OF CHEMICAL SUBSTANCES EITHER ALONE OR AS LUBRICATING INGREDIENTS IN A LUBRICATING COMPOSITION
    • C10M2215/00Organic non-macromolecular compounds containing nitrogen as ingredients in lubricant Compositions
    • C10M2215/22Heterocyclic nitrogen compounds
    • C10M2215/221Six-membered rings containing nitrogen and carbon only
    • CCHEMISTRY; METALLURGY
    • C10PETROLEUM, GAS OR COKE INDUSTRIES; TECHNICAL GASES CONTAINING CARBON MONOXIDE; FUELS; LUBRICANTS; PEAT
    • C10MLUBRICATING COMPOSITIONS; USE OF CHEMICAL SUBSTANCES EITHER ALONE OR AS LUBRICATING INGREDIENTS IN A LUBRICATING COMPOSITION
    • C10M2215/00Organic non-macromolecular compounds containing nitrogen as ingredients in lubricant Compositions
    • C10M2215/22Heterocyclic nitrogen compounds
    • C10M2215/225Heterocyclic nitrogen compounds the rings containing both nitrogen and oxygen
    • CCHEMISTRY; METALLURGY
    • C10PETROLEUM, GAS OR COKE INDUSTRIES; TECHNICAL GASES CONTAINING CARBON MONOXIDE; FUELS; LUBRICANTS; PEAT
    • C10MLUBRICATING COMPOSITIONS; USE OF CHEMICAL SUBSTANCES EITHER ALONE OR AS LUBRICATING INGREDIENTS IN A LUBRICATING COMPOSITION
    • C10M2215/00Organic non-macromolecular compounds containing nitrogen as ingredients in lubricant Compositions
    • C10M2215/22Heterocyclic nitrogen compounds
    • C10M2215/225Heterocyclic nitrogen compounds the rings containing both nitrogen and oxygen
    • C10M2215/226Morpholines
    • CCHEMISTRY; METALLURGY
    • C10PETROLEUM, GAS OR COKE INDUSTRIES; TECHNICAL GASES CONTAINING CARBON MONOXIDE; FUELS; LUBRICANTS; PEAT
    • C10MLUBRICATING COMPOSITIONS; USE OF CHEMICAL SUBSTANCES EITHER ALONE OR AS LUBRICATING INGREDIENTS IN A LUBRICATING COMPOSITION
    • C10M2215/00Organic non-macromolecular compounds containing nitrogen as ingredients in lubricant Compositions
    • C10M2215/24Organic non-macromolecular compounds containing nitrogen as ingredients in lubricant Compositions having hydrocarbon substituents containing thirty or more carbon atoms, e.g. nitrogen derivatives of substituted succinic acid
    • C10M2215/28Amides; Imides
    • CCHEMISTRY; METALLURGY
    • C10PETROLEUM, GAS OR COKE INDUSTRIES; TECHNICAL GASES CONTAINING CARBON MONOXIDE; FUELS; LUBRICANTS; PEAT
    • C10MLUBRICATING COMPOSITIONS; USE OF CHEMICAL SUBSTANCES EITHER ALONE OR AS LUBRICATING INGREDIENTS IN A LUBRICATING COMPOSITION
    • C10M2215/00Organic non-macromolecular compounds containing nitrogen as ingredients in lubricant Compositions
    • C10M2215/24Organic non-macromolecular compounds containing nitrogen as ingredients in lubricant Compositions having hydrocarbon substituents containing thirty or more carbon atoms, e.g. nitrogen derivatives of substituted succinic acid
    • C10M2215/30Heterocyclic compounds
    • CCHEMISTRY; METALLURGY
    • C10PETROLEUM, GAS OR COKE INDUSTRIES; TECHNICAL GASES CONTAINING CARBON MONOXIDE; FUELS; LUBRICANTS; PEAT
    • C10MLUBRICATING COMPOSITIONS; USE OF CHEMICAL SUBSTANCES EITHER ALONE OR AS LUBRICATING INGREDIENTS IN A LUBRICATING COMPOSITION
    • C10M2219/00Organic non-macromolecular compounds containing sulfur, selenium or tellurium as ingredients in lubricant compositions
    • C10M2219/08Thiols; Sulfides; Polysulfides; Mercaptals
    • C10M2219/082Thiols; Sulfides; Polysulfides; Mercaptals containing sulfur atoms bound to acyclic or cycloaliphatic carbon atoms
    • C10M2219/084Thiols; Sulfides; Polysulfides; Mercaptals containing sulfur atoms bound to acyclic or cycloaliphatic carbon atoms containing hydroxy groups; Derivatives thereof
    • CCHEMISTRY; METALLURGY
    • C10PETROLEUM, GAS OR COKE INDUSTRIES; TECHNICAL GASES CONTAINING CARBON MONOXIDE; FUELS; LUBRICANTS; PEAT
    • C10MLUBRICATING COMPOSITIONS; USE OF CHEMICAL SUBSTANCES EITHER ALONE OR AS LUBRICATING INGREDIENTS IN A LUBRICATING COMPOSITION
    • C10M2219/00Organic non-macromolecular compounds containing sulfur, selenium or tellurium as ingredients in lubricant compositions
    • C10M2219/09Heterocyclic compounds containing no sulfur, selenium or tellurium compounds in the ring
    • CCHEMISTRY; METALLURGY
    • C10PETROLEUM, GAS OR COKE INDUSTRIES; TECHNICAL GASES CONTAINING CARBON MONOXIDE; FUELS; LUBRICANTS; PEAT
    • C10MLUBRICATING COMPOSITIONS; USE OF CHEMICAL SUBSTANCES EITHER ALONE OR AS LUBRICATING INGREDIENTS IN A LUBRICATING COMPOSITION
    • C10M2219/00Organic non-macromolecular compounds containing sulfur, selenium or tellurium as ingredients in lubricant compositions
    • C10M2219/10Heterocyclic compounds containing sulfur, selenium or tellurium compounds in the ring
    • CCHEMISTRY; METALLURGY
    • C10PETROLEUM, GAS OR COKE INDUSTRIES; TECHNICAL GASES CONTAINING CARBON MONOXIDE; FUELS; LUBRICANTS; PEAT
    • C10MLUBRICATING COMPOSITIONS; USE OF CHEMICAL SUBSTANCES EITHER ALONE OR AS LUBRICATING INGREDIENTS IN A LUBRICATING COMPOSITION
    • C10M2219/00Organic non-macromolecular compounds containing sulfur, selenium or tellurium as ingredients in lubricant compositions
    • C10M2219/10Heterocyclic compounds containing sulfur, selenium or tellurium compounds in the ring
    • C10M2219/102Heterocyclic compounds containing sulfur, selenium or tellurium compounds in the ring containing sulfur and carbon only in the ring
    • CCHEMISTRY; METALLURGY
    • C10PETROLEUM, GAS OR COKE INDUSTRIES; TECHNICAL GASES CONTAINING CARBON MONOXIDE; FUELS; LUBRICANTS; PEAT
    • C10MLUBRICATING COMPOSITIONS; USE OF CHEMICAL SUBSTANCES EITHER ALONE OR AS LUBRICATING INGREDIENTS IN A LUBRICATING COMPOSITION
    • C10M2219/00Organic non-macromolecular compounds containing sulfur, selenium or tellurium as ingredients in lubricant compositions
    • C10M2219/10Heterocyclic compounds containing sulfur, selenium or tellurium compounds in the ring
    • C10M2219/104Heterocyclic compounds containing sulfur, selenium or tellurium compounds in the ring containing sulfur and carbon with nitrogen or oxygen in the ring
    • CCHEMISTRY; METALLURGY
    • C10PETROLEUM, GAS OR COKE INDUSTRIES; TECHNICAL GASES CONTAINING CARBON MONOXIDE; FUELS; LUBRICANTS; PEAT
    • C10MLUBRICATING COMPOSITIONS; USE OF CHEMICAL SUBSTANCES EITHER ALONE OR AS LUBRICATING INGREDIENTS IN A LUBRICATING COMPOSITION
    • C10M2219/00Organic non-macromolecular compounds containing sulfur, selenium or tellurium as ingredients in lubricant compositions
    • C10M2219/10Heterocyclic compounds containing sulfur, selenium or tellurium compounds in the ring
    • C10M2219/104Heterocyclic compounds containing sulfur, selenium or tellurium compounds in the ring containing sulfur and carbon with nitrogen or oxygen in the ring
    • C10M2219/106Thiadiazoles

Definitions

  • ABSTRACT This invention relates to new cyclic polymethylene phenoxy-aminopropanols and related compounds of the formula and to salts of such compounds, which are useful in coronary diseases, lowering blood pressure, as central nervous system depressants, water softening and corrosion inhibition.
  • the radical is a basic nitrogen containing radical of up to about 18 carbon
  • R is hydrogen, lower alkyl or aralkyl and n is O, l or 2.
  • R and the hydrogen attached to the oxygen will be deleted.
  • R' and R can be the same or different and can be hydrogen, lower alkyl, aryl, hydroxy. alkoxy, aryloxy or amino and n is l or 2.
  • lower alkyl as employed herein includes both straight and branched chain radicals of up to and including eight carbon atoms, for instance, methyl, ethyl, propyl, isopropyl, butyl, s-butyl, t-butyl, isobutyl, pentyl, hexyl, isohexyl, heptyl, 4,4-dimethylpentyl, oc tyl, 2,2,4-trimethylpentyl and the like.
  • the aryl-lower alkyl groups include benzyl, phenethyl and the like.
  • lower alkoxy includes straight and branched chain radicals of the structure RO- wherein R includes any of the above lower alkyl groups.
  • halogen includes each of the four halogens, but Cl and Br are preferred.
  • the amino groups include unsubstituted amino or monoor di-lower alkyl-amino groups, wherein lower alkyl is as defined above, such as amino, methyl amino, ethyl amino, isopropyl amino, heptylamino, dimethyl amino, diethyl amino, methyl ethyl amino, methyl butyl amino, ethyl i-propyl amino and the like.
  • the acyl radicals represented by R include lower fatty acid radicals such as acetyl, propionyl, butyryl, isobutyryl and the like, as well as long chain fatty acid radicals such as hexanoyl, heptanoyl, decanoyl, dodecanoyl and the like, monocyclic aryl and aralkanoic acid radicals such as benzoyl, phenacetyl and the like.
  • lower alkenyl refers to C to C aliphatic groups which include one double bond such as ally] and all isomers of propenyl, butenyl, pentenyl, hexenyl, heptenyl and octenyl.
  • monocyclic aryl as employed herein contemplates monocyclic carbocyclic aryl radicals, for instance, phenyl and substituted phenyl radicals, such as lower alkyl phenyl (e.g., 0-, mor p-tolyl, ethylphenyl, butylphenyl and the like, di(lower alkyl)phenyl (e.g., 2,4-dimethylphenyl, 3,5-diethylphenyl and the like) halophenyl (e.g., chlorophenyl, bromophenyl, iodophenyl, fluorophenyl), o-, mor p-nitrophenyl, dinitrophenyl, (e.g., 3,5-dinitrophenyl, 2,6- dinitrophenyl and the like), and trinitrophenyl (e.g., picryl) and alkoxyphenyl such as methoxyphenyl.
  • monocyclic cycloalkyl includes cyclic radicals containing from 3 to 6 ring members (e.g., cyclopropyl, cyclobutyl, cyclopentyl and cyclohexyl).
  • R and R each represents hydrogen, lower alkyl, lower alkenyl, hydroxy-lower alkyl and phenyllower alkyl forming such basic groups as amino, lower alkylamino, e.g., methylamino, ethylamino, isopropylamino, di(lower alkyl)amino, e.g., dimethyl- LII amino, diethylamino, dipropylamino, lower alkenylamino, e.g., allylamino, di(lower alkenyl)amino, e.g., diallylamino, (hydroxy-lower alkyl)amino, e.g., hydroxyethylamino, di(hydroxy-lower alkyl)amino, e.g., di(hydroxyethyl)amino, phenyl(lower alkyl- )amino, e.g.
  • radical may form a heterocyclic radical.
  • R and R may together represent the carbon (and hydrogen) and the oxygen, sulfur or nitrogen atoms which, with the nitrogen or carbon atom in the above group, form a or 6-membered nitrogen heterocyclic containing not more than one hetero atom in addition to the nitrogen already shown in the group and less than 21 atoms in the radical (excluding hydrogen).
  • the heterocyclic radicals may include one to three substituents including lower alkoxy or lower alkyl as defined hereinbefore; trifluoromethoxy; trifluoromethylmercapto; N,N-dialkylsulfamoyl groups, such as N,N-dimethylsulfamoyl; lower alkanoyl groups where R is lower alkyl) as defined hereinbefore, such asacetyl, propionyl, and the like; hydroxy-lower alkyl, such as hydroxymethyl,2-hydroxyethyl or the like; hydroxy-lower alkoxy-lower alkyl, such as 2-(2-hydroxyethoxy)ethyl, or the like; lower alkanoyl-lower alkyl, such as Z-heptanoyloxyethyl; carbolower alkoxy, such as carbomethoxy, carboethoxy, carbopropoxy, or the like; or'2-(lower alkanoyloxy-lower alkoxy)low
  • heterocyclic radicals represented by 31 are the following: piperidino; (lower alkyl)piperidino [e.g., 2-, 3-, or 4-(lower alkyl)piperidino or 4-(N-lower alkyl )-piperidino, such as 2-(ethyl)piperidino or 4-(N- isopropyl)-piperidino]; di(lower alkyl)piperidino [e.g., 2,4-, 2,5- or 3,5-di(lower alkyl)piperidino, such as 2,4- dimethyl piperidino or 2,5-di-t-butyl piperidino]; (lower alkoxy)piperidino [e.g., 2-methoxypiperidino or 3-methoxypiperidino]; hydroxypiperidino [e.g., 3-
  • hydroxy- 'or 4-hydroxypiperidino ; aminomethylpiperidino [e.g., 4-aminomethylpiperidino]; pyrrolidino; (lower alkyl)pyrrolidino [e.g., 3-
  • methylpyrrolidino di(lower alkyl)pyrrolidino [e.g., 3,4-dimethylpyrrolidino];- (lower alkoxy)pyrrolidino [e.g., 2-methoxypyrrolidino]; morpholino; (lower alkyl)morpholino [e.g., 3-methylmorpholino]; di(lower alkyl)morpholino, [e.g., 3,5-dimethylmorpholino]; (lower alkoxy)-morpholino, [e.g., 2- methoxymorpholino]; thiamorpholino; (lower alkyl)- thiamorpholino [e.g., 3-methylthiamorpholino]; di(- lower alkyl)thiamorpholino, [e.g., 3,5- dimethylthiamorpholino], (lower alkoxy)thiamorpholino, [e.g., 3-methoxythiamorpholino]; piperazino;
  • lower alkyl is methyl, ethyl, n-propyl, isopropyl, etc]; lower alkoxy piperidyl, [e.g., 3-methoxypiperidyl or 2- 4 ethoxypiperidyl]; hydroxypiperidyl [e.g., 3-hydroxyor 4-hydroxypiperidyl]; aminomethylpiperidyl,[e. g.
  • pyrrolidyl lower alkyl pyrrolidyl, [e.g., l-N-methylpyrrolidyl]; di(lower alkyl)pyrrolidyl, [e.g., 2,3-dimethylpyrrolidyl]; lower alkoxy pyrrolidyl, [e.g, 4-N-methoxypyrrolidyl]; morpholinyl; (lower alkyl)-morpholinyl, [e.g., 3- methylmorpholinyl]; di-(lower alkyl)-morph0linyl, [e.g., 3-methyl-4-N-ethylmorpholinyl1; (lower alkoxy)- morpholinyl, [e.g, 2-ethoxymorpholinyl]; thiamorpholinyl; (lower alkyl)thiamorpholino, [e.g., 3- eth
  • the compounds of formula I form acid addition salts with inorganic and organic acids. These acid addition salts frequently provide useful means for isolating the products from reaction mixtures by forming the salt in a medium in which it is insoluble.- The free base may then be obtained by neutralization, e.g., with a base such as sodium hydroxide. Then any other salt may again be formed from the free base and the appropriate inorganic or organic acid.
  • hydrohalides especially the hydrochloride and hydrobromide which are preferred, sulfate, nitrate, phosphate, borate, acetate, oxalate, tartrate, maleate, citrate, succinate, benzoate, ascorbate, salicylate, methanesulfonate, benzenesulfonate, toluenesulfonate and the like.
  • Quaternary ammonium salts are also formed, e.g., by reacting the free base with an alkylating agent, e.g., lower alkyl halide such as methyl chloride, ethyl bromide or the like, lower alkyl sulfate such as methyl sulfate, aralkyl halides such as benzyl chloride, aralkyl sulfates such as benzyl sulfate and the like.
  • an alkylating agent e.g., lower alkyl halide such as methyl chloride, ethyl bromide or the like
  • lower alkyl sulfate such as methyl sulfate
  • aralkyl halides such as benzyl chloride
  • aralkyl sulfates such as benzyl sulfate and the like.
  • R, R, R R R R R, R and R are all hydrogen, R is hydrogen or lower alkyl especially hydrogen, R is lower alkyl, especially isopropyl, and X is O, Y is O and Z is and the aminopropanol C me 1- or a-position.
  • the X-Z-Y group will be attached to the cycloalkyl ring on two vicinal carbon atoms.
  • the new compounds of this invention are useful as water softeners and for inhibiting the corrosivity of engine lubricants.
  • a compound of formula I or a physiologically acceptable acid addition salt may be incorporated in a conventional dosage form such as tablet, capsule, elixir, injectable or the like along with the necessary carrier material, excipient, lubricant, buffer or the like.
  • Single or divided doses of about 5 to 25 mg/kg/day, preferably about 4 to 10 mg/kg, two to four times daily may be administered in dosage forms as described above.
  • the above epoxy-propoxy-naphthalene can be converted to the formula I compounds of the invention by heating with an amine VII R H R2 in an inert organic solvent, such as n-propanol, benzene or toluene, e.g., for about 16 to 24 hours; the reactants may also be heated in a Parr pressure reactor at a temperature within the range of from about 70 to about 1 10 for 6 12 Compounds of formulae 1 and Ill wherein Z is prescut
  • compounds of structure I can be pre- I pared by reacting a starting material of structure [V with a compound of the structure XII XII R6 R1 R3 of the R4 l I which are epoxidized by reaction with a suitable oxidizingagent such as m-chloroperbenzoic acid or other peracid in a solvent such as chloroform. to compounds of structure Vl.
  • a suitable oxidizingagent such as m-chloroperbenzoic acid or other peracid in a solvent such as chloroform.
  • Preferred compounds of the invention include those having the structure to form ethers XIII structure Rn X EXAMPLE 1 3a.9a-cis-1-(tert-Butylamino)-3-[(3a, 4,9,9atetrahydro-Z, 2-dimethyl-2H-naphtho[2,3-d]dioxol-5- yl)-oxy]-2-propanol A. cis-5,6,7,8-Tetrahydro-1,6,7-naphthalenetriol A solution of 29.2 g. (0.2 mole) of 5,8-dihydro-1- naphthol and 40 ml. of acetic anhydride in 100 ml of pyridine is prepared.
  • the haloacetal from part A is dissolved in ethanol containing excess diethylamine and the mixture heated at C for 48 hours in a bomb. The mixture is cooled and water and solvent stripped therefrom. The residue is purified bychromatography on Alumina 11 neutral to yield the title compound.
  • EXAMPLE 4 3a,9a-cis-1-(iso-Propylamino)-3-[3a,4,9,9atetrahydro-2H-naphtho[2,3d]dioxol-2-one-5yl]-oxy]- 2-propanol
  • 5,8-Dihydro-l-naphthol, benzyl ether A solution of 5,8-dihydro-l-naphthol (73 g., 0.5 M) in 400 ml. DMSO is treated with 0.5 M ofsodium methoxide. The mixture is cooled in an ice bath while benzyl bromide (85.5 g., 0.5 M) is added dropwise.
  • the mixture has to be shaken periodically since there is difficulty in stirring. Toward the end of the addition the mixture is allowed to warm to -45", and stirring is continued for 2-3 hours after addition is complete. The mixture is then poured into 1 liter H 0 and the product is extracted into ether. The ether extracts are washed with 10% NaOH, dried and the solvent is removed in vacuo to give a' quantitative yield of crude crystalline product.
  • the filtrate is taken to dryness in vacuo and the residue taken up in 250 ml of methanol and treated in the cold with a solution of 40 g of sodium hydroxide in 200 ml of water. After stirring overnight, the bulk of the methanol is removed in vacuum, and the product extracted into chloroform. After dyring and solvent removal, the product is induced to crystallize by trituration with hexane.
  • the mixture is cooled in an ice bath and treated dropwise with 0.5 mole benzyl bromide with shaking periodically.
  • the mixture is gradually allowed to warm up to about 45 toward the end of addition.
  • the mixture is stirred 3 hrs. longer, then poured into 1 liter H 0 and extracted into ether. Extracts are washed twice with 10% NaOH, dried, taken to dryness leaving almost a quantitative yield of crystalline 5,8-dihydro-lnaphthyl benzyl ether.
  • EXAMPLE 8 3a,9a-tran s-l-(iso-Propylamino)-3[3a,4,9,9atetrahydro-2-diethylaminomethyl-2H-naphtho[2,3d]- l thia-3-oxol-5(and 8)yl)-oxy]-2-propanol
  • oroethylidene-6-mercapto-5,6,7,8- tetrahydronaphthalene-l .7-diol Employing the mercaptan prepared in Example 6B in lieu of cis-5,6.7.8-tetrahydro-l,6,7-naphthalenetriol in the procedure of Example 3.
  • EXAMPLE ll EXAMPLE l2 3a,9a-trans-l-(iso-Propylamino)-3[(3a,4,9,9atetrahydro-2H-naphtho[2,3d]-l-thia-3-oxol-2-thion- 5(and 8)yl)oxy]-2-propanol A.
  • 6-Amino-5,6,7,8-tetrahydronaphthalene dio1-O-benzyl ether O,N-thiocarbonate A solution of 0.l m each of the epoxide benzyl ether of Example 6A and butylisothiocyanate in xylene added to a solution containing 0.004 m of tributyl phosphine oxide and 0.003 m of lithium bromide in xylene and the mixture heated under reflux overnight. After cooling, solvent is removed and the crude mixture of products purified on neutral Alumina lll to give the title compound.
  • the suspension was poured into a mixture of 50 ml of NaOH and 100 g of ice.
  • the aqueous layer was extracted with CH Cl and the combined organic layers were washed with water and satd. NaCl soln, dried and evaporated in vacuo to give the title compound.
  • the crude azide was dissolved in 100 ml of ether and added to a suspension of L'AH (5 g) in 250 ml of ether. After several hours at reflux, the mixture was decomposed with aqueous potassium carbonate and the filtrate freed of solvent.
  • Aminooxazoline derivative of 6(and 7)amino- 5,6,7,8-tetrahydronaphthalene-l,7(and 6)diol An intimate mixture of 12.6 g (0.05 mole) of 6,7- epoxy-5,6,7,8-tetrahydro-l-naphthyl benzyl ether and 25 g of guanidine are heated to l40l80C until gas evolution ceases. The reaction mixture is cooled, and the product recrystallized from alcohol.
  • EXAMPLE 1 7 6-Hydroxy-5(and 8)-(2-hydroxy-3-butylaminopropoxy)-5,6,7,8-tetrahydronaphthalene-7-acetic acid lactone A. 1,7(and 6)Dihydroxy-5,6,7,8-tetrahydro-6(and 7)-naphthalene-acetic acid lactone A solution of 12.6 g (0.05 mole) of 6,7-epoxy' 5,6,'7,S-tetrahydronaphthol benzyl ether and 7.5 g (0.05 mole) of diethylmalonate in ml of absolute ethanol containing about 0.01 mole of sodium ethoxide was brought to reflux for several hours. The mixture was cooled, treated with concentrated HCl and warmed to effect hydrolysis and decarboxylation. Removal of solvent left crude lactone which was purified by chromatography on silica gel.
  • EXAMPLE l8 EXAMPLE l9 Bis acetonide derivative of the product of Example 1
  • the product of Example 1 is dissolved in acetone in v the presence ofa catalytic amount of p-toluene sulfonic acid and the mixture is refluxed to form the title compound.
  • EXAMPLE 20 The Bis-butylidene derivative of 2,3-cis-l,2,3,4- tetrahydro-5-[2-hydroxy-3-(tert-butylamino)- propoxy]-2,3-naphthalenediol A. cis-5,6,7,8-Tetrahydro-1,6,7-naphthalenetriol A solution of 29.2 g. (0.2mole) of 5,8-dihydro-lnaphthol and 40 ml. of acetic anhydride in 100 ml. of pyridine is prepared. After 16 hr. the solvent is removed in vacuo and the residue dissolved in ether and washed with 200 ml.
  • phenyl-lower alkyl R and R are each hydrogen or lower alkyl; and wherein lower alkyl is alkyl having up to eight carbon atoms.
  • R is lower alkyl; and R" and R are each selected from the group consisting of hydrogen and lower alkyl; and wherein lower alkyl is alkyl having up to eight carbon atoms.

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Lubricants (AREA)
  • Heterocyclic Compounds Containing Sulfur Atoms (AREA)
  • Furan Compounds (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
  • Plural Heterocyclic Compounds (AREA)

Abstract

This invention relates to new cyclic polymethylene phenoxyaminopropanols and related compounds of the formula AND TO SALTS OF SUCH COMPOUNDS, WHICH ARE USEFUL IN CORONARY DISEASES, LOWERING BLOOD PRESSURE, AS CENTRAL NERVOUS SYSTEM DEPRESSANTS, WATER SOFTENING AND CORROSION INHIBITION.

Description

[Jite States Patent [191 Hauclr et al.
[111 3,856,818 Dec. 24,1974
[ TRICYCLIC PHENOXY AMINOPROPANOLS [75] Inventors: Frederic Peter Hauck, Somerville;
Christopher Michael Cimarusti, Somerset, both of NJ.
[73] Assignee: E. R. Squibb & Sons, Inc.,
Princeton, NJ.
[22] Filed: July 3, 1972 [2l] Appl. No.: 268,313
[56] References Cited 8 UNITED STATES PATENTS 3/1966 8/1969 Koppe 260/3405 Primary Examiner-Richard J. Gallagher Assistant Examiner-James H. Turnipseed Attorney, Agent, or F [rm-Lawrence S. Levinson; Merle J. Smith; Donald J. Barrack van Proosdij-Hartzema.... 260/340.5
[57] ABSTRACT This invention relates to new cyclic polymethylene phenoxy-aminopropanols and related compounds of the formula and to salts of such compounds, which are useful in coronary diseases, lowering blood pressure, as central nervous system depressants, water softening and corrosion inhibition.
6 Claims, N0 Drawings TlRlCYClLIC PHENOXY AMINOPROPANOLS This invention relates to new chemical compounds of the formula 1).. m M and salts thereof, wherein XZY together with two carbons of the cycloalkyl ring form a to 7-membered ring, R, R R R and R are the same or different and can be hydrogen or lower alkyl, R, R and R" are the same or different and can be hydrogen, lower alkyl, aralkyl, lower alkoxy, carboxy, monocyclic cycloalkyl, lower alkenyl, nitro, halogen, acyl, amino, acylamino, RO(CH ),,I where R is hydrogen, lower alkyl or aralkyl and n is 0 or l; X and Y may be the same or different and can be CH =N, O*, -S, NR"-, O-CH SCH or NR- CH where R is hydrogen, lower alkyl or aryl, Z can be I V a BQWMBJZ, where R and R can be hydrogen, lower alkyl, cycloalkyl, aryl. haloalkyl, amino or 'aminoalkyl;
o-cm-; -o-c ll ll ll a. V 9c-9 and X-ZY- can be taken together to form O-C=N or -S-C=N--, 've
the radical is a basic nitrogen containing radical of up to about 18 carbon, R is hydrogen, lower alkyl or aralkyl and n is O, l or 2.
Where in Formula I the O-Z N group is present, then, in such case, R and the hydrogen attached to the oxygen will be deleted. Thus, the present invention inwherein R' and R can be the same or different and can be hydrogen, lower alkyl, aryl, hydroxy. alkoxy, aryloxy or amino and n is l or 2.
The term lower alkyl as employed herein includes both straight and branched chain radicals of up to and including eight carbon atoms, for instance, methyl, ethyl, propyl, isopropyl, butyl, s-butyl, t-butyl, isobutyl, pentyl, hexyl, isohexyl, heptyl, 4,4-dimethylpentyl, oc tyl, 2,2,4-trimethylpentyl and the like.
The aryl-lower alkyl groups include benzyl, phenethyl and the like.
The term lower alkoxy includes straight and branched chain radicals of the structure RO- wherein R includes any of the above lower alkyl groups.
The term halogen includes each of the four halogens, but Cl and Br are preferred.
The amino groups include unsubstituted amino or monoor di-lower alkyl-amino groups, wherein lower alkyl is as defined above, such as amino, methyl amino, ethyl amino, isopropyl amino, heptylamino, dimethyl amino, diethyl amino, methyl ethyl amino, methyl butyl amino, ethyl i-propyl amino and the like.
The acyl radicals represented by R include lower fatty acid radicals such as acetyl, propionyl, butyryl, isobutyryl and the like, as well as long chain fatty acid radicals such as hexanoyl, heptanoyl, decanoyl, dodecanoyl and the like, monocyclic aryl and aralkanoic acid radicals such as benzoyl, phenacetyl and the like.
The term lower alkenyl" refers to C to C aliphatic groups which include one double bond such as ally] and all isomers of propenyl, butenyl, pentenyl, hexenyl, heptenyl and octenyl.
The term monocyclic aryl as employed herein contemplates monocyclic carbocyclic aryl radicals, for instance, phenyl and substituted phenyl radicals, such as lower alkyl phenyl (e.g., 0-, mor p-tolyl, ethylphenyl, butylphenyl and the like, di(lower alkyl)phenyl (e.g., 2,4-dimethylphenyl, 3,5-diethylphenyl and the like) halophenyl (e.g., chlorophenyl, bromophenyl, iodophenyl, fluorophenyl), o-, mor p-nitrophenyl, dinitrophenyl, (e.g., 3,5-dinitrophenyl, 2,6- dinitrophenyl and the like), and trinitrophenyl (e.g., picryl) and alkoxyphenyl such as methoxyphenyl.
' The terms monocyclic cycloalkyl includes cyclic radicals containing from 3 to 6 ring members (e.g., cyclopropyl, cyclobutyl, cyclopentyl and cyclohexyl).
In the basic nitrogen containing radical in formula I, R and R each represents hydrogen, lower alkyl, lower alkenyl, hydroxy-lower alkyl and phenyllower alkyl forming such basic groups as amino, lower alkylamino, e.g., methylamino, ethylamino, isopropylamino, di(lower alkyl)amino, e.g., dimethyl- LII amino, diethylamino, dipropylamino, lower alkenylamino, e.g., allylamino, di(lower alkenyl)amino, e.g., diallylamino, (hydroxy-lower alkyl)amino, e.g., hydroxyethylamino, di(hydroxy-lower alkyl)amino, e.g., di(hydroxyethyl)amino, phenyl(lower alkyl- )amino, e.g., benzylamino, phenethylamino, N-(lower alkyl)phenyl(lower alkyl)amino, e.g., N- methylbenzylamino, and the like.
The
radical may form a heterocyclic radical. The symbols R and R may together represent the carbon (and hydrogen) and the oxygen, sulfur or nitrogen atoms which, with the nitrogen or carbon atom in the above group, form a or 6-membered nitrogen heterocyclic containing not more than one hetero atom in addition to the nitrogen already shown in the group and less than 21 atoms in the radical (excluding hydrogen). The heterocyclic radicals may include one to three substituents including lower alkoxy or lower alkyl as defined hereinbefore; trifluoromethoxy; trifluoromethylmercapto; N,N-dialkylsulfamoyl groups, such as N,N-dimethylsulfamoyl; lower alkanoyl groups where R is lower alkyl) as defined hereinbefore, such asacetyl, propionyl, and the like; hydroxy-lower alkyl, such as hydroxymethyl,2-hydroxyethyl or the like; hydroxy-lower alkoxy-lower alkyl, such as 2-(2-hydroxyethoxy)ethyl, or the like; lower alkanoyl-lower alkyl, such as Z-heptanoyloxyethyl; carbolower alkoxy, such as carbomethoxy, carboethoxy, carbopropoxy, or the like; or'2-(lower alkanoyloxy-lower alkoxy)lower alkyl such as Z-(decanoyloxyethoxy)ethyl, or thelike,
Illustrative of the heterocyclic radicals represented by 31 are the following: piperidino; (lower alkyl)piperidino [e.g., 2-, 3-, or 4-(lower alkyl)piperidino or 4-(N-lower alkyl )-piperidino, such as 2-(ethyl)piperidino or 4-(N- isopropyl)-piperidino]; di(lower alkyl)piperidino [e.g., 2,4-, 2,5- or 3,5-di(lower alkyl)piperidino, such as 2,4- dimethyl piperidino or 2,5-di-t-butyl piperidino]; (lower alkoxy)piperidino [e.g., 2-methoxypiperidino or 3-methoxypiperidino]; hydroxypiperidino [e.g., 3-
hydroxy- 'or 4-hydroxypiperidino]; aminomethylpiperidino [e.g., 4-aminomethylpiperidino]; pyrrolidino; (lower alkyl)pyrrolidino [e.g., 3-
methylpyrrolidino]; di(lower alkyl)pyrrolidino [e.g., 3,4-dimethylpyrrolidino];- (lower alkoxy)pyrrolidino [e.g., 2-methoxypyrrolidino]; morpholino; (lower alkyl)morpholino [e.g., 3-methylmorpholino]; di(lower alkyl)morpholino, [e.g., 3,5-dimethylmorpholino]; (lower alkoxy)-morpholino, [e.g., 2- methoxymorpholino]; thiamorpholino; (lower alkyl)- thiamorpholino [e.g., 3-methylthiamorpholino]; di(- lower alkyl)thiamorpholino, [e.g., 3,5- dimethylthiamorpholino], (lower alkoxy)thiamorpholino, [e.g., 3-methoxythiamorpholino]; piperazino; (lower alkyl)piperazino, [e.g., N-methylpiperazino]; di(lower alkyl)piperazino, [e.g., 2,5- dimethylpiperazino or 2,6-dimethylpiperazino]; (lower alkoxy)piperazino,[e.g., Z-methoxypiperazino]; (hydroxy-lower alkyl)piperazino, [e.g., N-(2- hydroxyethyl)piperazino]; (lower alkanoyloxy-lower alkyl)-piperazino, [e.g., N-(2-heptanoyloxyethyl)- piperazino or N-(2-propionyloxyethyl)piperazino]; (hydroxy-lower alkoxylower alkyl)piperazino, [e.g., (hydroxymethoxymethyl)piperazino]; (carbo-lower alkoxy)piperazino, [e.g., N-(carbomethoxy-, carboethoxy-, or carbopropoxy)piperazino]; piperidyl; (lower alkyl)piperidyl [e.g., 1-, 2-, 3- or 4-(lower alkyl)- piperidyl, such as l-N-methylpiperidyl or 3- ethylpiperidyl]; di(lower alkyl)piperidyl, [e.g., 2,4-, 2,5. or 3,5-di(lower alkyl)-piperidyl wherein lower alkyl is methyl, ethyl, n-propyl, isopropyl, etc]; lower alkoxy piperidyl, [e.g., 3-methoxypiperidyl or 2- 4 ethoxypiperidyl]; hydroxypiperidyl [e.g., 3-hydroxyor 4-hydroxypiperidyl]; aminomethylpiperidyl,[e. g. 4, -aminoethylpiperidyl]; pyrrolidyl, lower alkyl pyrrolidyl, [e.g., l-N-methylpyrrolidyl]; di(lower alkyl)pyrrolidyl, [e.g., 2,3-dimethylpyrrolidyl]; lower alkoxy pyrrolidyl, [e.g, 4-N-methoxypyrrolidyl]; morpholinyl; (lower alkyl)-morpholinyl, [e.g., 3- methylmorpholinyl]; di-(lower alkyl)-morph0linyl, [e.g., 3-methyl-4-N-ethylmorpholinyl1; (lower alkoxy)- morpholinyl, [e.g, 2-ethoxymorpholinyl]; thiamorpholinyl; (lower alkyl)thiamorpholino, [e.g., 3- ethylthiamorpholinyl]; di(lower alkyl)thiamorpholinyl, [e.g., 3-methyl-4-N-ethylthiamorpholinyl]; lower alkoxy thiamorpholino, [e.g., 3-methoxythiamorpholinyl1; piperazinyl; alkyl, dialkyl, alkoxy or hydroxy-lower alkyl substituted piperazinyl.
The compounds of formula I form acid addition salts with inorganic and organic acids. These acid addition salts frequently provide useful means for isolating the products from reaction mixtures by forming the salt in a medium in which it is insoluble.- The free base may then be obtained by neutralization, e.g., with a base such as sodium hydroxide. Then any other salt may again be formed from the free base and the appropriate inorganic or organic acid. Illustrative are the hydrohalides, especially the hydrochloride and hydrobromide which are preferred, sulfate, nitrate, phosphate, borate, acetate, oxalate, tartrate, maleate, citrate, succinate, benzoate, ascorbate, salicylate, methanesulfonate, benzenesulfonate, toluenesulfonate and the like. Quaternary ammonium salts are also formed, e.g., by reacting the free base with an alkylating agent, e.g., lower alkyl halide such as methyl chloride, ethyl bromide or the like, lower alkyl sulfate such as methyl sulfate, aralkyl halides such as benzyl chloride, aralkyl sulfates such as benzyl sulfate and the like.
Preferred are those compounds wherein R, R, R R R R R, R and R are all hydrogen, R is hydrogen or lower alkyl especially hydrogen, R is lower alkyl, especially isopropyl, and X is O, Y is O and Z is and the aminopropanol C me 1- or a-position.
In all of the above embodiments of the invention, the X-Z-Y group will be attached to the cycloalkyl ring on two vicinal carbon atoms.
The new compounds of this invention are useful as water softeners and for inhibiting the corrosivity of engine lubricants.
They are also useful as central nervous system depressants and antifibrillatory agents, for example, in arresting cardiac arrhythmia in mammals, e.g., by inhibition of beta adrenergic receptors in the myocardium. For these purposes a compound of formula I or a physiologically acceptable acid addition salt may be incorporated in a conventional dosage form such as tablet, capsule, elixir, injectable or the like along with the necessary carrier material, excipient, lubricant, buffer or the like. Single or divided doses of about 5 to 25 mg/kg/day, preferably about 4 to 10 mg/kg, two to four times daily may be administered in dosage forms as described above.
Compounds of formula I can be prepared by reacting a phenol of the structure (IV) R (011),,
Z l l v gl lal isehlorine or bromine), such as epichlorohydrin in a solvent such as dimethylsulfoxide (as described herein) to form l,2,3,4-tetrahydro5-[2,3-epoxy propoxy]-naphthalenes of the structure v R 0 /R3 R11 0-'-C--C 15 /X\ a 5 'u Rt 2 (C lu 2O Rm a The above epoxy-propoxy-naphthalene can be converted to the formula I compounds of the invention by heating with an amine VII R H R2 in an inert organic solvent, such as n-propanol, benzene or toluene, e.g., for about 16 to 24 hours; the reactants may also be heated in a Parr pressure reactor at a temperature within the range of from about 70 to about 1 10 for 6 12 Compounds of formulae 1 and Ill wherein Z is prescut, that is In e R1 a /Rl QJLJPLN X a 1 1 Lil j where Z is R12 BIL-CH 'or C I X3 can be prepared by reacting a compound of formula ll, that is 11 m R R" R 0+ wag M H 1h R1 z with a ketone or an aldehyde of the structure R12 \C=O or IW-CHO R" VIII IX wherein R and R are the same or different and can be lower alkyl. monocyclic aryl or lower alkylmonocyclic aryl in the presence of asolvent boiling below ahout C. such as benzene or chloroform to form an oxaz olidine compound of the structure X 3 R0117 Rs R11 o h b cn R8 in I l-R Z O -11" cim n n Compounds of formula lll wherein Z is or S=C/ can be prepared by reacting compounds of formula ll with phosgene (COCl or thiophosgcnc (CSCl to form compounds of the structure XI R0 R1 R3 X gal n where Z is O or S.
Alternatively, compounds of structure I can be pre- I pared by reacting a starting material of structure [V with a compound of the structure XII XII R6 R1 R3 of the R4 l I which are epoxidized by reaction with a suitable oxidizingagent such as m-chloroperbenzoic acid or other peracid in a solvent such as chloroform. to compounds of structure Vl. This method is particularly useful where R. R and/or R are other than hydrogen and R and R are hydrogen.
The cyclic polymethylene phenols of structure lV employed as starting materials herein are disclosed in copending application Ser. No. 268,300, filed July 3, 1972 entitled TRlCYCLlC TETRAHYDRO NAPH- THALENEOLS AND RELATED COMPOUNDS.
Preferred compounds of the invention include those having the structure to form ethers XIII structure Rn X EXAMPLE 1 3a.9a-cis-1-(tert-Butylamino)-3-[(3a, 4,9,9atetrahydro-Z, 2-dimethyl-2H-naphtho[2,3-d]dioxol-5- yl)-oxy]-2-propanol A. cis-5,6,7,8-Tetrahydro-1,6,7-naphthalenetriol A solution of 29.2 g. (0.2 mole) of 5,8-dihydro-1- naphthol and 40 ml. of acetic anhydride in 100 ml of pyridine is prepared. After 16 hr. the solvent is removed in vacuo and the residue dissolved in ether and washed with 200 ml. of 5% hydrochloric acid, water, 200 ml. of 10% sodium hydroxide, saturated salt solution and dried. Solvent removal gives 34.2 g (90.5) of crude acetate which is dissolved in 900 ml. of acetic acid and 36 ml. of water. 53.3 g. (0.32 mole) of silver acetate is added followed by 40.6 g. (0.16 g-atom) of iodine. The slurry is heated with good stirring at 85: 10 for 3 hr. under nitrogen, cooled and filtered. The filtrate is evaporated in vacuo and the residue dissolved in 250 ml. of methanol and cooled to A solution of 40 g. of sodium hydroxide in 200 ml. of water is added under nitrogen and the mixture stirred overnight. The bulk of the methanol is removed in vacuo whereupon a solid forms. The solid is separated by filtration, dissolved in 150 ml. of water and acidified with 20 ml. of concentrated hydrochloric acid. Cooling gives a solid which is filtered and dried to give 16.5 g. 2,3 cis- 5 ,6,7,8-tetrahydro-l ,6,7-naphthalenetriol m.p. 184.5-187. Three recrystallizations from absolute ethanolgive the analytical sample, m.p. 188-188.5".
Anal. Calcd for C1QH|2O3: c, 66.65; H. 6.71
Found: C, 66.19; H, 6.68
B. Acetonide, of cis-5,6,7,8-tetrahydro-l,6.7- naphthalenetriol A slurry of 5.4 g of the cis-5,6,7,8-tetrahydro-l,6,7- naphthalene-triol in 50 ml of 2,2-dimethoxy propane is treated with 150 mg. of TsOH (solution in min).
After 1 hr. the solution is partitioned between ether and satd bicarbonate solution. The organic layer is dried and evaporated to give 6.58 g. essentially TLC homogeneous. Crystallization of a small sample from hexane/ethyl acetate gives the title material of mp. 130.5-13l.5.
C. Acetonide of 3-(5,6,7,8-tetrahydro-cis-6,7- dihydroxynaphthoxy)-1,Z-epoxypropane A solution of 5.8 g (0.026 mole) of the above phenol and 1.51 g (0.028 mole) of sodium methoxide is prepared in 100 ml of methanol and the solvent removed in vacuo. The residue is dissolved in 75 ml of DMSO, ca. ml distilled out (40 at 0.2 mm) and 4 ml of epichlorohydrin added. After stirring overnight at room temperature under nitrogen the solution is poured into 1.2 liters of water and extracted with ether (2 X 250 ml). The ether is washed twice with water, dried and evaporated to give 7.2 g of tan oil of the above title.
D. 3a,9a-cis-l-(tert-Butylamino)-3-[(3a, 4,9,9atetrahydro-2,Z-dimethyI-ZH-naphthol2,3-dldioxol-S- yl)-oxyl]-2-propanol The above epoxide is heated at 80 5 in the small Parr bomb with 45 ml of t-butyl amine for 16 hours. The excess amine is removed in vacuo and the residue crystallized from a mixture of hexane and ether to give 3.3 g. Recrystallization from 100 ml of 10-15% ether in pentane gives 1.5 g, mp 85-88.
Anal. Calcd for C H N0 C, 68.74; H, 8.94; N,
4.01. Found: C, 68.71; H, 9.06; N, 3.79.
EXAMPLE 2 3a,9a-cis-l-(tert-Butylamino)-3[(3a,4,9,9atetrahydro-2-propyl-2H-naphtho[2,3d]dioxol-5-yl)- oxy]-2-propanol A. O ,O -Butylidene-5 ,6,7,8-tetrahydro-l ,6,7- naphthalenetriol A solution of 3.6 g (0.02 moles) of the triol of Example l-A in 50 ml. of benzene, and 1.5 of butanal in the presence of 0.1 g p-toluene sulfonic acid are mixed together and stirred for several hrs. Water is removed by azeotropic distillation and the residue is taken to dryness to yield the title compound.
B. 3a,9a-cis-l-(tert-Butylamino)-3[(3a,4,9.9atetrahydro-2-propyl-2H-naphtho[2,3d]dioxol-5-yl)- oxy]-2-propanol I The procedure of Example 1C and D is followed in employing the triol of part A to form the title compound.
EXAMPLE 3 3a,9a-cis-1-(tert-Butylamino)-3[(3a,4,9,9atetrahydro-2-diethylaminomethyl)-2H- naphtho[2,3d]dioxol-5yl)-oxy]-2-propan0l A. 6,7-B-chloroethylidene-5,6,7,8-tetrahydro-1,6,7- naphthalenetriol A solution of 27 g (0.15 moles) of cis-5,6,7,8- tetrahydro-1,6,7-naphthalenetriol prepared as described in Example 1 in 250 ml of benzene and 25 g of diethoxyethyl' chloride in the presence of 0.2 g ptoluene sulfonic acid are mixed together for several hours. Water is removed by azeotropic distillation and the residue taken to dryness to yield the title comound.
B. O. O -B-Diethylaminoethylidene-5,6,7,8- tetrahydro-1,6,7-naphthalenetriol The procedure described in J. Pharm and Pharmac. 23, 649 (1971) is followed.
The haloacetal from part A is dissolved in ethanol containing excess diethylamine and the mixture heated at C for 48 hours in a bomb. The mixture is cooled and water and solvent stripped therefrom. The residue is purified bychromatography on Alumina 11 neutral to yield the title compound.
C. 3a,9a-cis-1-(tert-Butylamino)-3[(3a,4,9,9atetrahydro-2-diethylaminomethyl)-2H- naphtho[2,3d]dioxol-5-yl)-oxy]-2-propanol The procedure of Example 1C and D is followed employing the triol of part B to form the title compound.
EXAMPLE 4 3a,9a-cis-1-(iso-Propylamino)-3-[3a,4,9,9atetrahydro-2H-naphtho[2,3d]dioxol-2-one-5yl]-oxy]- 2-propanol A. 5,8-Dihydro-l-naphthol, benzyl ether A solution of 5,8-dihydro-l-naphthol (73 g., 0.5 M) in 400 ml. DMSO is treated with 0.5 M ofsodium methoxide. The mixture is cooled in an ice bath while benzyl bromide (85.5 g., 0.5 M) is added dropwise. The mixture has to be shaken periodically since there is difficulty in stirring. Toward the end of the addition the mixture is allowed to warm to -45", and stirring is continued for 2-3 hours after addition is complete. The mixture is then poured into 1 liter H 0 and the product is extracted into ether. The ether extracts are washed with 10% NaOH, dried and the solvent is removed in vacuo to give a' quantitative yield of crude crystalline product.
. obtained.
A small sample (4g) of this is recrystallized twice from methanol to give the title compound, 1.3 g., mp 70-74.
Anal. Calcd for C H O:C, 86.40: H, 6.83
Found: C, 86.58; H, 6.6
B. cis-5,6,7,8-tetrahydro-l,6,7-naphthalenetriol-O'- benzyl ether To 47.2 g (0.20 mole) of the above ether dissolved in 900 ml of acetic acid containing 30 ml of water is added 53.3 g (0.32 mole) of silver acetate with vigorous stirring followed by 40.6 g (0.16 g. atom) ofiodine. After 1 hour, the slurry is heated to 8595 for 3 hours under nitrogen, cooled and filtered. The filtrate is taken to dryness in vacuo and the residue taken up in 250 ml of methanol and treated in the cold with a solution of 40 g of sodium hydroxide in 200 ml of water. After stirring overnight, the bulk of the methanol is removed in vacuum, and the product extracted into chloroform. After dyring and solvent removal, the product is induced to crystallize by trituration with hexane.
C. 5,6,7,8-Tetrahydro-l ,6.7-naphthalenetriol-O- benzyl ether-O ,O -carbonate in accordance with the procedure set out in Arch. Pharm. 304 590 (1971 a solution of 27 g (0.1 mole) ofthediol of part B (0.1 m)-in 200 ml of THF is treated with 1.7 g (0.1 m) of N,N-carbonyl diimidazole and heated under reflux for 2 hours. After cooling, the mixture is poured into water and the productextracted into CHCl dried and purified on deactivated silica gel to give the title compound.
D. 3a,9a-cis-l-(iso-Propylamino)-3-[3a,4,9,9atetrahydro-2H-naphtho[2,3d]dioxol-2-one-5yl]-oxy]- 2-propanol g The procedure of Example 1C and D (substituting isopropylamine for t-butylamine) is followed employing the above carbonate to form the title compound.
EXAMPLE 5 3a,9a-cis-l-(iso-Propylamino)-3-[3a,4.9,9atetrahydro-2-ethyl-2-methyl-2H-naphtho[2,3d]dioxol- 6yl)-oxyl]-2propanol A. 5,8Dihydro-2-naphthol I The procedure of Marshall, et al., Can. J. Chem., 47. 3127 1969) is followed exactly. From 25.0 g of B-naphthol is obtained 18.9 g of crude product. NMR analysis indicated it to contain ca. 40%.of the desired 5,8-dihydro-2-naphthol an 60% of 5,6,7,8-tetrahydro- 2-naphthol.
B. cis-5,6,7,8-Tetrahydro-2,6,7-naphthalene triol The 18.9 g. of crude product was converted to the acetate by the procedure used in Example 1 and the resulting oil (23.8 g) was heated at 90 for 3 hr. with 300 ml. of aceticacid, 20 ml. of water, 23.5 g. of silver acetate and 18.0 g. of iodine. The slurry was cooled and filtered. The filtrate was evaporated and the residue stirred overnight under nitrogen with 100 ml. each of water and methanol and 20 g. of sodium hydroxide. The methanol was removed in vacuo and the residue acidified at with 155 ml. of 122 hydrochloric acid. The oil which separated crystallized when shaken in a separatory funnel with chloroform. Filtration gave 7.9 g. of tan solid. Recrystallization from ethanol/ethyl acetate gave in several crops 4.03 g., mp l93195.5.
C. 0 0 -2-Butylidene-5,6,7,8-tetrahydro-2,6,7- naphthalenetriol Following the procedure of Example 2 substituting for butanal, methyl ethyl ketone, the title compound is D. 3a,9a-cis-l-(iso-Propylamino)-3-[3a,4,9,9atetrahydro-2-ethyl-2-methyl-2H-naphtho[2,3d]dioxol- 6yl)-oxy]-2-propanol The procedure of Example 4D is followed employing the above triol to form the title compound.
EXAMPLE 6 3a,9a-trans-l-(tert-Butylamino)3-[3a,4,9,9atetrahydro-2,2-dimethyl-2H-naphtho[2,3dl-l-thia-3- oxol-5(and 8)-oxy]2-propanol A. 6,7-Epoxy-5,6,7,8-tetrahydro-l-naphthyl benzyl ether A solution of73 g. (0.5 m)of5,8-dihydro-1-naphthol in ml. DMSO is treated with 0.5 in sodium methoxide. The mixture is cooled in an ice bath and treated dropwise with 0.5 mole benzyl bromide with shaking periodically. The mixture is gradually allowed to warm up to about 45 toward the end of addition. The mixture is stirred 3 hrs. longer, then poured into 1 liter H 0 and extracted into ether. Extracts are washed twice with 10% NaOH, dried, taken to dryness leaving almost a quantitative yield of crystalline 5,8-dihydro-lnaphthyl benzyl ether.
A solution of 23.6 g. (0.10 m') of the above ether in 250 ml. CHCl is treated with a solution of 0.11 m mchloroperbenzoic acid in Cl-lCl at 10-l5C and stirred overnight. After filtration, the organic filtrate is washed with dilute K CO dried and freed of solvent, leaving crude solid epoxy ether.
B. 7(and 6)Mercapto-S,6,7,S-tetrahydronaphthalene-l,6,(and 7)diol A solution of the above epoxyether (12.6 g. 0.05 m) in ethanol was added to an aqueous solution of sodium sulfide and the resulting mixture warmed for serveral hours. After cooling and acidification with acetic acid, the product was extracted into Cl-ICl dried and freed of solvent to leave a mixture of isomeric mercapto alcohols of I structure:
and HS rnoy EXAMPLE 7 3a, 9a-trans-l-(iso-Propylamino)-3[3a.4,9,9atetrahydro-2-butyl-2-methyl-2H-naphtho[2,3d]-l-thia- 3-oxol-5(and 8)yl)oxy]-2-propanol A. S.O-2-Hexylidene--mercapto-S,6,7,8- tetrahydronaphthalenel ,7-diol Employing the mercaptan prepared in Example 68 in lieu of the l,2,3,4-tetrahydro-l ,2,5-naphthalenetriol in the procedure of Example 2, and replacing the butanal with methyl butyl ketone, the following compound is obtained 11 (Ina (In: S on3 \C/ W CH3 4Ha\ 04H, 0
B. 3a,9a-trans-l-(iso-propylamino)-3[3a.4,9,9a-
tetrahydro-2-butyl-2-methyl-2H-naphtho[2,3d]-l -thia- 3oxol-5(and 8)oxy]-2-propanol The procedure of'Example 1C and D is-followed em-- ploying the above diol to form the title compound.
EXAMPLE 8 3a,9a-tran s-l-(iso-Propylamino)-3[3a,4,9,9atetrahydro-2-diethylaminomethyl-2H-naphtho[2,3d]- l thia-3-oxol-5(and 8)yl)-oxy]-2-propanol A. S,O -B-Ch|oroethylidene-6-mercapto-5,6,7,8- tetrahydronaphthalene-l .7-diol Employing the mercaptan prepared in Example 6B in lieu of cis-5,6.7.8-tetrahydro-l,6,7-naphthalenetriol in the procedure of Example 3. the following compound is obtained on O B. 3a,9a-trans-l-(iso-Propylamino)-3[3a,4,9,9atetrahydro-2-diethylaminomethyl 2H-naphtho[2.3d]- l-thia-3-oxol-5(and 8)-yl)-oxy]-2-propanol The procedure of Example 4D is followed by employing the above diol to form the title compound.
EXAMPLE 9 3a,9a-trans-l-(iso-Propylamino)-3[3a,4,9,9atetrahydro-2H-naphtho[2,3d]-l-thia-3-oxol-2-one- 5(and 8)-yl)oxy]-2-propanol A. 6-Mercapto-5,6,7,8-tetrahydronaphthalene-l,7- diol S,O -carbonate-O'-benzyl ether Employing the benzyl ether of the mercaptan of Example 6B in the procedure of Example 4 in lieu of the diol, the following compound is obtained ClCHg-C O CH: C6H5 0 S ace 3a,9a-trans-l-(iso-Propylamino)-3[3a,4,9,9atetrahydro-2H-napht ho[2,3d]-l-thia-3-oxol-2-one- 5(and 8)-yl)oxy]-2-propanol The above compound is debenzylated by reaction with Pd/C in the presence of pyridine and the resulting diol is subjected to the procedure of Example 1C and D to form the title compound.
EXAMPLE l0 7-Hydroxy-l(and 4)-(2-hydroxy-3'-tert butylamino propoxy)-5.6.7.8tctrahydro-fi-naphthyloxyacetic acid lactone A. 7(and 6)Hydroxy-S.6,7.8-tetrahydro-6( and 7 )-naphthyloxyacetic-acid lactone The above compound is prepared by reacting 0.] mole 5.6,7,8-tetrahydro-l,6,7-naphthalenetriol O'- benzyl ether with 0.] mole of Cl-CH CO C H in I00 ml of dimethoxyethane in the presence of 3 g NaH and heating the mixture at reflux for several hours and thereafter separating the product from the reaction mixture by chromatography on silica gel.
Catalytic debenzylation over 5% Pd/c in ethanol then affords the free phenol.
B. 7-Hydroxy-l(and 4)-(2-hydroxy-3'-tert butylamino propoxy)-5,6,7.S-tetrahydro-o-naphthyloxyacetic acid lactone The procedure of Example lC and D is followed cmploying the above phenol to form the title compound.
EXAMPLE ll EXAMPLE l2 3a,9a-trans-l-(iso-Propylamino)-3[(3a,4,9,9atetrahydro-2H-naphtho[2,3d]-l-thia-3-oxol-2-thion- 5(and 8)yl)oxy]-2-propanol A. 6-Mercapto-5,6.7,8-tetrahydro-naphthalene-l,7- diol-O-benzyl ether O ,S-thiocarbonate The procedure of Examples 9 and 4 are followed employing the benzyl ether of the mercaptan of Example 68 and thiophosgene in place of phosgene to form the above compound.
B. 3a.9a-trans-l-(iso-Propylamino)-3[(3a,4,9,9atetrahydro-2H-naphtho[2.3d] l -thia-3-oxol-2-thion- 5(and 8)yl)oxy1-2-propanol Catalytic debenzylation of the benzyl ether over 5% Pd on C in the presence of ethanol yields the free phenol. The free phenol is subjected to the procedure of Example 4D to form the title compound.
EXAMPLE l3 3a,9a-trans-l-(tert-Butylamino)-3[93a,4,9,9atetrahydro-2H-naphtho[2,3d]-l-oxy-3-azol-2-one- 5(and 8)yl)oxy]-2-propanol A. 6(and 7)-Amino-5,6,7,8-tetrahydronaphthalenel,7-(and 6)-diol-O-benzyl ether 0 N-carbonate A solution of 0.1 m each of the epoxide benzyl ether of Example 6A and phenyl isocyanate in xylene is added to a solution containing 0.004 m oftributyl phosphine oxide and 0.003 m of lithium bromide in xylene and the mixture heated under reflux overnight. After cooling, solvent is removed and the crude mixture of products purified on neutral Alumina III to give the title compound.
Method Ref. 'l'el. Letters 809 (1971) B. 3a,9a-trans-l-(tert-Butylamino)-3[(3a,4,9,9a-
nol. The free phenol is subjected to the procedure of 5 Example 1C and D to form the title compound.
EXAMPLE l4 3a,9a-trans-l-(tert-Butylamino)-3[3a,9,9a-tetrahydro- ZH-naphtho [2,3d]-l-oxa-3-azol-2-thion-5-(and 8)yl)- oxyl-2-propanol A. 6-Amino-5,6,7,8-tetrahydronaphthalene dio1-O-benzyl ether O,N-thiocarbonate A solution of 0.l m each of the epoxide benzyl ether of Example 6A and butylisothiocyanate in xylene added to a solution containing 0.004 m of tributyl phosphine oxide and 0.003 m of lithium bromide in xylene and the mixture heated under reflux overnight. After cooling, solvent is removed and the crude mixture of products purified on neutral Alumina lll to give the title compound.
Method Ref. Tet. Letters 809 (1971).
B. '3a,9a-trans-l-(tert-Butylamino)-3[3a,4,9,9atetrahydro-2H-naphtho[2,3d]-l-oxa-3-azol-2-thion- 5(and 8)yl)-oxy]-2-propanol Catalytic debenzylation of the above benzyl ether over 5% Pd and C in the presence of ethanol yields the free phenol. The free phenol is subjected to the procedure of Example 1C and D to yield the title compound.
EXAMPLE l5 3a,9a-cis-l-(tert-Butylamino)-3[3a,4,9,9a-tetrahydro- 2-phenyl-lH-naphth[2,3d]oxazol-5(and 8 )yl)oxy]-2- propanol A. 6,7-Epoxy-5,6,7,8-tetrahydro-l-naphthol benzyl ether A solution of 12.8 (0.054 m) of 5,7-dihydro-lnaphthol benzyl ether in 150 ml of CH CI was cooled to and 8.9 g 0.052 mole ofm-chloroperbenzoic acid was added over a period of 5 min. and the mixture was stirred overnight at room temperature.
The suspension was poured into a mixture of 50 ml of NaOH and 100 g of ice. The aqueous layer was extracted with CH Cl and the combined organic layers were washed with water and satd. NaCl soln, dried and evaporated in vacuo to give the title compound.
B. trans 6(and 7)-Amino-5,6,7,8-tetrahydro-ll,7(and 6)-naphthalenediol A solution of 6,7-epoxy-5,6,7,8-tetrahydro-1- naphthol O-benzyl ether 12.6 g (0.05 mole) in 200 ml dioxane was heated to 40 and a solution of sodium azide (6,8 g, 0tll mole) in water ml) was added dropwise. The mixture was heated under reflux overnight, cooled, filtered and the solvent was removed in vacuo.
The crude azide was dissolved in 100 ml of ether and added to a suspension of L'AH (5 g) in 250 ml of ether. After several hours at reflux, the mixture was decomposed with aqueous potassium carbonate and the filtrate freed of solvent.
C. C-Phenylimidazole derivative of 6-amino-5,6,7,8- tetrahydronaphthalenel ,7-diol O-benzyl ether The trans amino alcohol was converted to its N- benzoyl derivative with benzoyl chloride-pyridine. This is added portionwise to excess thionyl chloride and then kept at 5060 for 3 hrs. Removal of excess reagent in vacuum leaves the crude cis oxazoline as its HCl salt, which is recrystallized from ethanol-ether.
D. 3a,9a-cis-l (tert-Butylamino)-3[3a,4,9,9a tetrahydro-2-phenyl-lH-naphth[2,3d]oxazol-5(and 8)yl)oxy]-2-propanol Catalytic debenzylation of the above benzyl ether over 5% Pd/C in the presence of ethanol yields the free phenol which is converted to the title compound by the procedure of Example 1C and D.
EXAMPLE l6 l-(tert-Butylamino)-3[3a,4,9,9a-tetrahydro-2-aminol-H-naphth-[2,3d]oxazol-5(and 8)yl)oxy]-2propanol A. Aminooxazoline derivative of 6(and 7)amino- 5,6,7,8-tetrahydronaphthalene-l,7(and 6)diol An intimate mixture of 12.6 g (0.05 mole) of 6,7- epoxy-5,6,7,8-tetrahydro-l-naphthyl benzyl ether and 25 g of guanidine are heated to l40l80C until gas evolution ceases. The reaction mixture is cooled, and the product recrystallized from alcohol.
B. l-(tert'Butylamino)-3[3a,4,9,9a-tetrahydro-2- amino-1-Hnaphth[2,3d]oxazol-5(and 8)yl)oxy]-2- propanol The free phenol obtained on catalytic debenzylation is subjected to the procedure of Example 4D to form the title compound.
EXAMPLE 1 7 6-Hydroxy-5(and 8)-(2-hydroxy-3-butylaminopropoxy)-5,6,7,8-tetrahydronaphthalene-7-acetic acid lactone A. 1,7(and 6)Dihydroxy-5,6,7,8-tetrahydro-6(and 7)-naphthalene-acetic acid lactone A solution of 12.6 g (0.05 mole) of 6,7-epoxy' 5,6,'7,S-tetrahydronaphthol benzyl ether and 7.5 g (0.05 mole) of diethylmalonate in ml of absolute ethanol containing about 0.01 mole of sodium ethoxide was brought to reflux for several hours. The mixture was cooled, treated with concentrated HCl and warmed to effect hydrolysis and decarboxylation. Removal of solvent left crude lactone which was purified by chromatography on silica gel.
Catalytic debenzylation over 5% Pd on C in ethanol provided the free phenol.
B. 6- Hydroxy-5(and 8)-(2-hydroxy-3-butylaminopropoxy)-5,6,7,8-tetrahydronaphthalene-7-acetic acid lactone The procedure of Example 1C and D is followed employing the above phenol to form the title compound.
EXAMPLE l8 EXAMPLE l9 Bis acetonide derivative of the product of Example 1 The product of Example 1 is dissolved in acetone in v the presence ofa catalytic amount of p-toluene sulfonic acid and the mixture is refluxed to form the title compound.
EXAMPLE 20 The Bis-butylidene derivative of 2,3-cis-l,2,3,4- tetrahydro-5-[2-hydroxy-3-(tert-butylamino)- propoxy]-2,3-naphthalenediol A. cis-5,6,7,8-Tetrahydro-1,6,7-naphthalenetriol A solution of 29.2 g. (0.2mole) of 5,8-dihydro-lnaphthol and 40 ml. of acetic anhydride in 100 ml. of pyridine is prepared. After 16 hr. the solvent is removed in vacuo and the residue dissolved in ether and washed with 200 ml. of 5% hydrochloric acid, water, 200 ml. of 10% sodium hydroxide, saturated salt solution and dried. Solvent removal gives 34.2 g. (90.5%) of crude acetate which is dissolved in 900 ml. of acetic acid and 36 ml. of water. 53.3 g. (0.32 mole) of silver acetate is added followed by 40.6 g. g. (0.16 g-atom) of iodine. The slurry is heated with good stirring at 85: 10 for 3 hr. under nitrogen, cooled and filtered. The filtrate is evaporated in vacuo and the residue dissolved in 250 ml. of methanol and cooled to A solution of 40 g. of sodium hydroxide in 200 ml. of water is added under nitrogen and the mixture stirred overnight. The bulk of the methanol is removed in vacuo whereupon a solid forms. The solid is separated by filtration, dissolved in 150 ml. of water and acidified with 20 ml. of concentrated hydrochloric acid. Cooling gives a solid which is filtered anddried to give 16.5 g. 2,3cis-5,6,7,8- tetrahydro-l,6,7-naphthalenetriol) m.p: 184.5187. Three recrystallizations from absolute ethanol give the analytical sample, m.p. 188l88.5.
Anal. Calcd for C H O C, 66.65; H, 6.71
Found: C, 66.19; H, 6.68.
B. 2,3-cis-l,2,3,4-Tetrahydro-5-[2,3-(epoxy)- propoxy]-2,3-naphthalenediol A solution of 1.20 g. (0.03 mole) of sodium methoxide and 5.4 g. (0.03 mole) of cis-5,6,7,8-tetrahydro- 1,6.7--naphthalenetriol in 200 ml. of methanol is prepared under nitrogen. The residue obtained upon solvent removal is stirred overnight with 200 ml. of dimethylsulfoxide and 4.65 g. (0.05 mole) of epichlorohydrin under nitrogen. The bulk of the solvent is removed at 50 at 0.1 mm. and the residue dissolved in 100 ml. of water. Extraction with chloroform X 200 ml.) gives a solid which is recrystallized from 150 ml. of hexane-ethyl acetate to give epoxy diol of the above title.
C. 2,3-cis-l,2,3,4-Tetrahydro-5-[2-hydroxy-3-(tertbutylamino)-propoxy]-2,3-naphthalenediol A mixture of 3.0 g. of 2,3-cis-1,2,3,4-tetrahydro-5- [2,3-(epoxy)-propoxy]-2,3-naphthalenediol (m.p. 104-107, one spot on TLC-alumina, 5% methanol in chloroform, iodine visualization) and 22 ml of t-butyl amine is heated at 85-95 for hours in a Parr bomb and the excess amine removed in vacuo. The solid obtained by trituration of the residue with ether is filtered and recrystallized from benzene to give 3.4 g, m.p. 124-l36.
l. A compound having the structure R3 0CH1CH(]J-NR2 0 R11 I I4 H V R! on R i/ R17 Ru RIO or a physiologically acceptable acid-addition salt thereof, wherein R is lower alkyl; R and R are hydrogen or methyl; R, R and R are each hydrogen or a non-tertiary lower alkyljR is hydrogen, lower alkyl or.
phenyl-lower alkyl; R and R are each hydrogen or lower alkyl; and wherein lower alkyl is alkyl having up to eight carbon atoms.
2. A compound having the structure or a physiologically acceptable acid-addition salt thereof, wherein R is lower alkyl; and R" and R are each selected from the group consisting of hydrogen and lower alkyl; and wherein lower alkyl is alkyl having up to eight carbon atoms.
3. A compound in accordance with claim 2 wherein R and R are lower alkyl.
4. A compound in accordance with claim 2 wherein R and R are methyl.
5. A compound in accordance with claim 2 wherein R is isopropyl.
6. A compound in accordance with claim 2 having the name 3a,9a-cis-1-(tert-butylamino)-3-[(3a,4,9,9a-
- tetrahydro-2,2-dimethyl-2H-naphtho[ 2,3-d ]dioxol-5 oxyl-2-propanol.
Part 1 of 2 Y UNITED STATES PATENT @FFKCE cERTirrcA'rt OF t.
Patent No, 3,856,818 Dated December 24, 1974 Inventor-(s) Frederic P. Hauck and Christopher M. Cimarusti It is certified that error appears in the above-identified patent and that said Letters Patent are hereby corrected as shown below:
Column 1, line v44, the word "carbon," should be: carbons,-. Column 1, lines 49 to 55, that portion of formula II that reads:
3 l 3 l R R R R I l C--N should be: C N
I 3 I 4 R 4 2 Column 1, lines 66 to 70, that portion that reads:
1-2 R R C, should be: C,
Column 4, line 44, after the word "aminopropanol" delete the letter "C" and substitute in its place: side Column 5, line 32 should read: 110 for 6-12 hours.
Column 6, line 44,- that portion reading: "R R should be:
Column 7, line 31, that portion reading: H, 6,71 should be:
Column 9, line 60, that portion reading: "122 hydrochloric acid" should be: 12% hydrochloric-acid.
Column 11, line 10, insert a hyphen after the 3 and before the word "oxol".
F ORM P04 050 (10-69) USCOMM-DC 60376-F'69 u.5. GOVERNMENT PRINTING OFFICE: I969 0-366-334.
2 2 1 Part UNlTfED STATES PATENT ormcE CERTIWCATE OF CRECTION Patent No. 856'8l8 Dated December 24, 1974 Inventor) Frederic P. Hauck and Christopher M. Cimarusti It is certified that error appears in the above-identified patent and that said Letters Patent are hereby corrected as shown below:
Column 11, line 33, insert a hyphen after the word:
"diethylaminomethyl".
' Column 12, line 29, insert: B. at the beginning of line 29..
Column 12, line 46, the line should read: tetrahydro-ZH- naphtho[2,3d]l-thia-B-oxol-Z-thion- Column 12, line 54, first line of thetitle of Example 13 should read: 3a,9a-transl(tert-Butylamino)-3[(3a,4,9,9a-
Column 13, line 9, first line of the title of Example 14 should read: 3a,9a-trans-l- (tert-Butylamino)-3[3a,4,9,9a-
tetrahydro- Column 13, line 48, at the end of the line, delete "l".
Column 14, line 55 should read: 7-acetic acid thiolactone Signed and sealed this 11th day of March 1975.
(SEAL) Attest:
Y C. MARSHALL DANN RUTH C. MASON Commissioner of Patents Attesting Officer and Trademarks DRM FO-105O (10-69)

Claims (6)

1. A COMPOUND HAVING THE STRUCTURE
2. A compound having the structure
3. A compound in accordance with claim 2 wherein R16 and R17 are lower alkyl.
4. A compound in accordance with claim 2 wherein R16 and R17 are methyl.
5. A compound in accordance with claim 2 wherein R2 is isopropyl.
6. A compound in accordance with claim 2 having the name 3a,9a-cis-1-(tert-butylamino)-3-((3a,4,9,9a-tetrahydro-2,2-dimethyl-2H -naphtho(2,3-d)dioxol-5-oxy)-2-propanol.
US00268313A 1972-07-03 1972-07-03 Tricyclic phenoxy aminopropanols Expired - Lifetime US3856818A (en)

Priority Applications (11)

Application Number Priority Date Filing Date Title
US00268313A US3856818A (en) 1972-07-03 1972-07-03 Tricyclic phenoxy aminopropanols
CA173,628A CA1000287A (en) 1972-07-03 1973-06-08 Tricyclic phenoxy aminopropanols
GB2818773A GB1434225A (en) 1972-07-03 1973-06-13 Tricyclic phenoxy aminopropanols
DE2332706A DE2332706A1 (en) 1972-07-03 1973-06-27 AMINOPROPANOL DERIVATIVES, THEIR SALTS, PROCESS FOR THEIR PRODUCTION AND MEDICINAL PRODUCTS CONTAINING THESE COMPOUNDS
CH963073A CH577459A5 (en) 1972-07-03 1973-07-02
HUSU823A HU167178B (en) 1972-07-03 1973-07-02
BE133067A BE801848A (en) 1972-07-03 1973-07-03 TRUCYCLIC PHENOXY-AMINOPROPANOLS AND THEIR PREPARATION
NL7309236A NL7309236A (en) 1972-07-03 1973-07-03
JP48076473A JPS4955652A (en) 1972-07-03 1973-07-03
FR7324448A FR2190463B1 (en) 1972-07-03 1973-07-03
AR248898A AR201666A1 (en) 1972-07-03 1973-07-03 PROCEDURE FOR PREPARING DERIVATIVES OF DIMETHYLTETRAHYDRONAFTODIOXOLIL-OXY-PROPANOLES

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US00268313A US3856818A (en) 1972-07-03 1972-07-03 Tricyclic phenoxy aminopropanols

Publications (1)

Publication Number Publication Date
US3856818A true US3856818A (en) 1974-12-24

Family

ID=23022403

Family Applications (1)

Application Number Title Priority Date Filing Date
US00268313A Expired - Lifetime US3856818A (en) 1972-07-03 1972-07-03 Tricyclic phenoxy aminopropanols

Country Status (11)

Country Link
US (1) US3856818A (en)
JP (1) JPS4955652A (en)
AR (1) AR201666A1 (en)
BE (1) BE801848A (en)
CA (1) CA1000287A (en)
CH (1) CH577459A5 (en)
DE (1) DE2332706A1 (en)
FR (1) FR2190463B1 (en)
GB (1) GB1434225A (en)
HU (1) HU167178B (en)
NL (1) NL7309236A (en)

Cited By (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4031225A (en) * 1975-06-18 1977-06-21 Sandoz Ltd. 4H-Benzo[4,5]cyclohepta[1,2-b]thiophenes
US4548943A (en) * 1984-05-11 1985-10-22 E. I. Du Pont De Nemours And Company Antiinflammatory, analgesic, or anti-primary dysmenorrheal arylmethylene- and arylmethylindenoimidazoles

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FI833685A0 (en) * 1983-10-11 1983-10-11 Farmos Oy FOERFARANDE FOER FRAMSTAELLNING AV EN AMINOALKOHOL
CA1338717C (en) * 1989-09-25 1996-11-12 Khashayar Karimian Nadolol

Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3239520A (en) * 1961-11-20 1966-03-08 Nl Combinatie Chem Ind N-(monocarbocyclic aryloxy-lower alkyl)-n' (diloweralkyl, or heterocyclic)-lower alkylene diamines
US3459782A (en) * 1963-08-26 1969-08-05 Boehringer Sohn Ingelheim 1-substituted phenoxy-2-hydroxy-3-isopropylamino-propanes

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1058822A (en) * 1963-07-30 1967-02-15 Ici Ltd 3-amino-2-hydroxypropoxy heterocyclic derivatives
ES330705A1 (en) * 1965-09-01 1967-10-01 Boehringer Sohn Ingelheim Procedure for the preparation of new substitute ariloxy-2-hydroxy-3-aminopropanes (Machine-translation by Google Translate, not legally binding)

Patent Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3239520A (en) * 1961-11-20 1966-03-08 Nl Combinatie Chem Ind N-(monocarbocyclic aryloxy-lower alkyl)-n' (diloweralkyl, or heterocyclic)-lower alkylene diamines
US3459782A (en) * 1963-08-26 1969-08-05 Boehringer Sohn Ingelheim 1-substituted phenoxy-2-hydroxy-3-isopropylamino-propanes

Cited By (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4031225A (en) * 1975-06-18 1977-06-21 Sandoz Ltd. 4H-Benzo[4,5]cyclohepta[1,2-b]thiophenes
US4548943A (en) * 1984-05-11 1985-10-22 E. I. Du Pont De Nemours And Company Antiinflammatory, analgesic, or anti-primary dysmenorrheal arylmethylene- and arylmethylindenoimidazoles

Also Published As

Publication number Publication date
NL7309236A (en) 1974-01-07
FR2190463B1 (en) 1976-12-31
CH577459A5 (en) 1976-07-15
JPS4955652A (en) 1974-05-30
BE801848A (en) 1974-01-03
DE2332706A1 (en) 1974-01-24
CA1000287A (en) 1976-11-23
AR201666A1 (en) 1975-04-08
GB1434225A (en) 1976-05-05
FR2190463A1 (en) 1974-02-01
HU167178B (en) 1975-08-28

Similar Documents

Publication Publication Date Title
US3789072A (en) Carboxamides
US3901906A (en) 2-(1-(2-fluoro-4-biphenylyl)ethyl)-2-oxazoline
US2852510A (en) Heterocyclic compounds and process for producing same
US3856818A (en) Tricyclic phenoxy aminopropanols
US3715353A (en) (aminoalkoxy-benzylidene)-2h-benzothiazine-3(4h)-ones and related compounds
US3155649A (en) Benzothiazocinones, related compounds and their preparation
US3842090A (en) Certain 1-aminomethyl-6-phenyl 4h-s-triazolo(4,3-a)(1,4)benzodiazepines
US4082773A (en) Tricyclic tetrahydro naphthaleneols and related compounds
GB1569039A (en) Derivatives of 10,11-dihydrobenzo(4,5)-cyclohepta(1,2-b)-pyrazolo(4,3-e)-pyridine-5(1h)one
US3706755A (en) Certain 4(3-(4-(phenyl)-3,6-dihydro-1(2h)pyridyl)-2 - hydroxy-propoxy)-benzophenones
US3657276A (en) Dibenzo (c f) thiazepine (1 2) compounds
US3478048A (en) 2,3;3a,12b - tetrahydro - 8h - dibenzo (3,4;6,7)cyclohept(1,2-d)oxazoles and derivatives
US3526671A (en) Aminoalkylated oximes of dibenzo(a,d)cyclohepten-5-ones
CA1063120A (en) Cyclic polymethylene phenoxy aminopropanols and related compounds
US3435042A (en) Novel morphanthridine derivatives
US3833655A (en) Amino-dibenzo(a,d)cyclohepta(1,4)dien-5-one compounds
US3668206A (en) Heterocyclic amine derivatives of 5,8-dihydronaphthyloxy propanols
US3435073A (en) 5-(n-benzyl-n-lower alkylaminoalkylene)-5h-dibenzo(a,d)cycloheptenes
US3180867A (en) Piperazine derivatives
US3906032A (en) Dihydroxy-tetrahydronaphthyoxyisobutyric acids and alkyl esters and salts thereof
US3738999A (en) 2,3,4,5-tetrahydro-2-phenyl-1,4-benzothiazepine, hydrochloride
US5071849A (en) Dihydropyrimidothiazine derivatives
US3624086A (en) Adamantanecarboxamidoalkanoic acid amides
US2807628A (en) Benzoxazepine compounds and method of producing same
US3357982A (en) 1-(5h-dibenzo [a, d] cyclohepten-5-yl)-4-alkylpiperazines